Potassium 5-carboxytetrazol-1-ide → 3,5-Dichlorobenzyl 4-(2-(N-methyl-2H-tetrazole-5-carboxamido)ethyl)piperidine-1-carboxylate
Reaction equation
[C:1]([C:4]1[N-:8][N:7]=[N:6][N:5]=1)(O)=[O:2].[K+].[CH3:10][NH:11][CH2:12][CH2:13][CH:14]1[CH2:19][CH2:18][N:17]([C:20]([O:22][CH2:23][C:24]2[CH:29]=[C:28]([Cl:30])[CH:27]=[C:26]([Cl:31])[CH:25]=2)=[O:21])[CH2:16][CH2:15]1>>[CH3:10][N:11]([CH2:12][CH2:13][CH:14]1[CH2:15][CH2:16][N:17]([C:20]([O:22][CH2:23][C:24]2[CH:25]=[C:26]([Cl:31])[CH:27]=[C:28]([Cl:30])[CH:29]=2)=[O:21])[CH2:18][CH2:19]1)[C:1]([C:4]1[N:8]=[N:7][NH:6][N:5]=1)=[O:2]Participants
3
Procedure
The title compound was prepared from potassium 5-carboxytetrazol-1-ide and 3,5-dichlorobenzyl 4-(2-(methylamino)ethyl)piperidine-1-carboxylate (Example 1 step 3) analogously to Example 16;
Sources & evidence
- ORD record
- ord-6654acaf999f4713bc8ac8cebc137b6b
- Source dataset
- uspto-grants-2016_08
- Patent number
- US09409895B2
Reaction notes
Loading…